Financial Performance Summary
Dabur India Limited reported financial results for the quarter ended June 30, 2026 [Q1 FY2027].
Key Financial Metrics:
- Consolidated Net Profit: ₹591 crore, representing 15% year-over-year growth
- Consolidated Revenue: ₹3,764 crore, representing 10.6% year-over-year growth
- Operating Profit: 11% growth (specific amount not disclosed)
- India FMCG Business Growth: 9.5% with underlying volume growth of 5%
Category-wise Performance Breakdown
Home & Personal Care (HPC): 12.3% growth
- Shampoo business: 23% growth
- Hair Oils category: 17.6% growth
- Oral Care business: 9% growth
- Toothpowder business: 13.1% growth
- Skin & Salon portfolio: 8.1% growth (led by Gulabari, Fem and OxyLife brands)
- Home Care business: 6% growth (despite supply chain disruptions from Middle East war)
Healthcare: 5.5% growth
- Digestives portfolio: 11.2% growth (Hajmola Tablets, Isabgol and PudinHara all growing at strong double digits)
- OTC business: Honitus brand grew 28%, Health juices grew 24%
- Health Supplements: Dabur Honey reported 8% growth
Food & Beverages (F&B): 7.2% growth
- Foods category: 29.2% growth
- Badshah business: 13.2% growth
- Beverages business: Mid-single-digit growth (recovered from rain-led demand disruptions)
- Premium beverage portfolio: Real Activ Juices grew 42%, Coconut Water grew 73%
International Business Performance
International Business reported 15.5% growth in INR terms with regional breakdown:
- Bangladesh: 34.3% growth
- Egypt: 28.4% growth
- Sub-Saharan Africa: 28% growth
- Turkey: 26.9% growth
- UK: 21.9% growth
- MENA: 8.6% growth (despite war-related disruptions in the region)
Strategic and Operational Highlights
Market Share & Portfolio Performance:
- Market share gains across over 90% of the portfolio
- Premium brands grew at twice the pace of regular brands
- New products accounted for 2.6% of Revenue
- Recent launches include Siens and Cheers brands
Geographic Performance:
- Rural demand grew 170 basis points ahead of urban demand (6.2% rural vs 4.6% urban)
- Eighth consecutive quarter of rural outperforming urban markets
- Urban growth supported by strong performance of modern trade, quick commerce and emerging channels
Management Commentary:
CEO Mohit Malhotra cited "persistent inflationary pressures, heightened geopolitical uncertainties in the MENA region, and volatile commodity markets" as operating challenges.
The company attributed performance to:
- Disciplined cost management through Project Samriddhi
- Operational efficiencies
- Judicious price increases
- Consumer-centric innovation
- Premiumization strategy
Outlook Concerns:
Management noted need to watch rural demand "especially in view of El-Nino, patchy monsoons and rising inflationary pressures."
Corporate Background
Dabur India Limited is described as "India's leading science-based Ayurveda major" with 142 years of legacy. The company's products reach 8 out of every 10 Indian households. Portfolio includes:
- Four ₹1,000 crore-plus brands
- Four ₹500 crore brands
- 15 brands in the ₹100-500 crore range